Table 1.

Potential drug-drug interaction information for Clopidogrel

Drug Name	Interaction Type
Bortezomib	May decrease serum concentrations of the active metabolite(s) of Clopidogrel
Drotrecogin Alfa	May enhance the adverse or toxic effect of Drotrecogin Alfa during concomitant therapy
Esomeprazole	May decrease serum concentrations of the active metabolite(s) of Clopidogrel
Ginkgo Biloba	May increase risk of bleeding during concomitant therapy with Clopidogrel
Lansoprazole	May decrease serum concentrations of the active metabolite(s) of Clopidogrel
Omeprazole	May decrease serum concentrations of the active metabolite(s) of Clopidogrel
Pantoprazole	May decrease serum concentrations of the active metabolite(s) of Clopidogrel
Rabeprazole	May decrease serum concentrations of the active metabolite(s) of Clopidogrel
Rivaroxban	Clopidogrel may enhance the anticoagulant effect of Rivaroxaban
Treprostinil	May increase risk of bleeding during concomitant therapy with Clopidogrel
Warfarin	May increase risk of bleeding during concomitant therapy with Clopidogrel